282 related articles for article (PubMed ID: 30165412)
21. Diagnosis and treatment of bacteremia and endocarditis due to Staphylococcus aureus. A clinical guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC).
Gudiol F; Aguado JM; Almirante B; Bouza E; Cercenado E; Domínguez MÁ; Gasch O; Lora-Tamayo J; Miró JM; Palomar M; Pascual A; Pericas JM; Pujol M; Rodríguez-Baño J; Shaw E; Soriano A; Vallés J
Enferm Infecc Microbiol Clin; 2015 Nov; 33(9):625.e1-625.e23. PubMed ID: 25937457
[TBL] [Abstract][Full Text] [Related]
22. Shock and persistent MRSA bacteremia.
DeSena HC; Steele RW; Young TW
Clin Pediatr (Phila); 2010 May; 49(5):509-11. PubMed ID: 20118078
[No Abstract] [Full Text] [Related]
23. Impact of a computerized alert system for bacteremia notification on the appropriate antibiotic treatment of Staphylococcus aureus bloodstream infections.
Kim J; Joo EJ; Ha YE; Park SY; Kang CI; Chung DR; Song JH; Peck KR
Eur J Clin Microbiol Infect Dis; 2013 Jul; 32(7):937-45. PubMed ID: 23361401
[TBL] [Abstract][Full Text] [Related]
24. A Healthcare Improvement Intervention Combining Nucleic Acid Microarray Testing With Direct Physician Response for Management of Staphylococcus aureus Bacteremia.
Eby JC; Richey MM; Platts-Mills JA; Mathers AJ; Novicoff WM; Cox HL
Clin Infect Dis; 2018 Jan; 66(1):64-71. PubMed ID: 29020181
[TBL] [Abstract][Full Text] [Related]
25. Impact of neutropenia on the clinical outcomes of Staphylococcus aureus bacteremia in patients with hematologic malignancies: a 10-year experience in a tertiary care hospital.
Ryu BH; Lee SC; Kim M; Eom Y; Jung J; Kim MJ; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS; Chong YP
Eur J Clin Microbiol Infect Dis; 2020 May; 39(5):937-943. PubMed ID: 31925572
[TBL] [Abstract][Full Text] [Related]
26. Cytokine responses to Staphylococcus aureus bloodstream infection differ between patient cohorts that have different clinical courses of infection.
McNicholas S; Talento AF; O'Gorman J; Hannan MM; Lynch M; Greene CM; Humphreys H; Fitzgerald-Hughes D
BMC Infect Dis; 2014 Nov; 14():580. PubMed ID: 25398383
[TBL] [Abstract][Full Text] [Related]
27. Executive summary of the diagnosis and treatment of bacteremia and endocarditis due to Staphylococcus aureus. A clinical guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC).
Gudiol F; Aguado JM; Almirante B; Bouza E; Cercenado E; Domínguez MÁ; Gasch O; Lora-Tamayo J; Miró JM; Palomar M; Pascual A; Pericas JM; Pujol M; Rodríguez-Baño J; Shaw E; Soriano A; Vallés J
Enferm Infecc Microbiol Clin; 2015 Nov; 33(9):626-32. PubMed ID: 25937456
[TBL] [Abstract][Full Text] [Related]
28. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006.
Laupland KB; Ross T; Gregson DB
J Infect Dis; 2008 Aug; 198(3):336-43. PubMed ID: 18522502
[TBL] [Abstract][Full Text] [Related]
29. Cardiac complications in children with Staphylococcus aureus bacteremia.
Friedland IR; du Plessis J; Cilliers A
J Pediatr; 1995 Nov; 127(5):746-8. PubMed ID: 7472829
[TBL] [Abstract][Full Text] [Related]
30. Occult Staphylococcus aureus bacteremia in adult emergency department patients: rare but important.
Fu CM; Tseng WP; Chiang WC; Lai MS; Chie WC; Chou HC; Hsueh PR; Ma MH; Fang CC; Chen SC; Chen WJ; Chen SY
Clin Infect Dis; 2012 Jun; 54(11):1536-44. PubMed ID: 22431800
[TBL] [Abstract][Full Text] [Related]
31. Time to positivity of follow-up blood cultures in patients with persistent Staphylococcus aureus bacteremia.
Choi SH; Chung JW
Eur J Clin Microbiol Infect Dis; 2012 Nov; 31(11):2963-7. PubMed ID: 22644058
[TBL] [Abstract][Full Text] [Related]
32. Relationship between pathogenic, clinical, and virulence factors of Staphylococcus aureus in infective endocarditis versus uncomplicated bacteremia: a case-control study.
Gallardo-García MM; Sánchez-Espín G; Ivanova-Georgieva R; Ruíz-Morales J; Rodríguez-Bailón I; Viñuela González V; García-López MV
Eur J Clin Microbiol Infect Dis; 2016 May; 35(5):821-8. PubMed ID: 26951263
[TBL] [Abstract][Full Text] [Related]
33. Pacemaker-induced Staphylococcus aureus mitral valve acute bacterial endocarditis complicated by persistent bacteremia from a coronary stent: Cure with prolonged/high-dose daptomycin without toxicity.
Cunha BA; Eisenstein LE; Hamid NS
Heart Lung; 2006; 35(3):207-11. PubMed ID: 16701116
[TBL] [Abstract][Full Text] [Related]
34. Methicillin-sensitive Staphylococcus aureus bacteraemia and endocarditis among injection drug users and nonaddicts: host factors, microbiological and serological characteristics.
Ruotsalainen E; Kardén-Lilja M; Kuusela P; Vuopio-Varkila J; Virolainen-Julkunen A; Sarna S; Valtonen V; Järvinen A
J Infect; 2008 Apr; 56(4):249-56. PubMed ID: 18314197
[TBL] [Abstract][Full Text] [Related]
35. Utility of qSOFA score in identifying patients at risk for poor outcome in Staphylococcus aureus bacteremia.
Minejima E; Delayo V; Lou M; Ny P; Nieberg P; She RC; Wong-Beringer A
BMC Infect Dis; 2019 Feb; 19(1):149. PubMed ID: 30760213
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of fosfomycin plus imipenem as rescue therapy for complicated bacteremia and endocarditis due to methicillin-resistant Staphylococcus aureus: a multicenter clinical trial.
del Río A; Gasch O; Moreno A; Peña C; Cuquet J; Soy D; Mestres CA; Suárez C; Pare JC; Tubau F; Garcia de la Mària C; Marco F; Carratalà J; Gatell JM; Gudiol F; Miró JM;
Clin Infect Dis; 2014 Oct; 59(8):1105-12. PubMed ID: 25048851
[TBL] [Abstract][Full Text] [Related]
37. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.
Fowler VG; Boucher HW; Corey GR; Abrutyn E; Karchmer AW; Rupp ME; Levine DP; Chambers HF; Tally FP; Vigliani GA; Cabell CH; Link AS; DeMeyer I; Filler SG; Zervos M; Cook P; Parsonnet J; Bernstein JM; Price CS; Forrest GN; Fätkenheuer G; Gareca M; Rehm SJ; Brodt HR; Tice A; Cosgrove SE;
N Engl J Med; 2006 Aug; 355(7):653-65. PubMed ID: 16914701
[TBL] [Abstract][Full Text] [Related]
38. Elevated soluble urokinase plasminogen activator receptor (suPAR) predicts mortality in Staphylococcus aureus bacteremia.
Mölkänen T; Ruotsalainen E; Thorball CW; Järvinen A
Eur J Clin Microbiol Infect Dis; 2011 Nov; 30(11):1417-24. PubMed ID: 21479972
[TBL] [Abstract][Full Text] [Related]
39. Outcomes and costs associated with a history of vancomycin exposure in patients with MRSA-related complicated bacteremia and infective endocarditis.
Brown J; Brown KA; Forrest A
Clin Ther; 2011 Oct; 33(10):1475-82. PubMed ID: 21925733
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of seven different enzyme-linked immunosorbent assays for serodiagnosis of Staphylococcus aureus bacteremia.
Ryding U; Espersen F; Söderquist B; Christensson B
Diagn Microbiol Infect Dis; 2002 Jan; 42(1):9-15. PubMed ID: 11821165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
